Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection

Immunology and Cell Biology

Volumn 77, Issue 4, 1999, Pages 324-330

  Cheers, Christina ^a   Janas, Michele ^a,c   Ramsay, Alistair ^b   Ramshaw, Ian ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Biology and Environment   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cytokines; Fowlpox; Immunotherapy; Interferon ; Interleukin 4; Intracellular bacteria; Listeria; Recombinant viruses; Vaccinia

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; FOWLPOX VIRUS; GENE EXPRESSION; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS EXPRESSION; VIRUS RECOMBINANT;

ANIMALIA; BACTERIA (MICROORGANISMS); FOWLPOX VIRUS; LISTERIA; LISTERIA MONOCYTOGENES; MAMMALIA; VACCINIA; VACCINIA VIRUS;

EID: 0032813982     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00829.x     Document Type: Article

References (33)

1. 1 Rolph MS, Ramshaw IA. Recombinant viruses as vaccines and immunological tools. Curr. Opin. Immunol. 1997; 9: 517-24.
2. 2 Ramshaw I, Ruby J, Ramsay A, Ada G, Kurapiah G. Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo. Immunol. Rev. 1992; 127: 157-82.
3. 3 Ramshaw IA, Andrew ME, Phillips SM, Boyle DB, Coupar BEH. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature 1987; 329: 545.
4. 4 Kohonen-Corish MR, King NJ. Woodhams CE, Ramshaw IA. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur. J. Immunol. 1990; 20: 157-61.
5. 5 Sambhi SK, Kohonen-Corish MR, Ramshaw IA. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc. Natl Acad. Sci. USA 1991; 88: 4025-9.
6. 6 Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994; 264: 561-3.
7. 7 Ramsay AJ, Leong KH, Boyle D, Ruby J, Ramshaw IA. Enhancement of mucosal IgA responses by intcrleukins 5 and 6 encoded in recombinant vaccine vectors. Reprod. Fertil. Dev. 1994; 6: 389-92.
8. 8 Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA. Iterleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J. Virol. 1996; 70: 7103-7.
9. 9 Silva RA, Pais TF, Appelberg R. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections. J. Immunol. 1998; 161: 5578-85.
10. 10 Mocci S, Dalrymple SA, Nishinakamura R, Murray R. The cytokine stew and innate resistance to L. monocytogenes. Immunol. Rev. 1997; 158: 107-14.
11. 11 Unanue ER. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 1997; 158: 11-25.
12. 12 Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-112, IFN-g). Curr. Opin. Immunol. 1997; 9: 17-23.
13. 13 Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-γ. J. Immunol. 1994; 152: 1884-7.
14. 14 Zhan Y, Cheers C. Control of IL-12 and IFN-γ production in response to live or dead bacteria by TNF and other factors. J. Immunol. 1998; 161: 1447-53.
15. 15 Havell EA. Evidence that tumour necrosis factor has an important role in antibacterial resistance. J. Immunol. 1989; 143: 2894-9.
16. 16 Liu Z, Simpson RJ, Cheers C. Role of IL-6 activation of T cells in acquired cellular resistance to Listeria monocytogenes. J. Immunol. 1994; 152: 5375-80.
17. 17 Kopf M, Baumann H, Freer G et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-42.
18. 18 Haak-Frendscho M, Brown JF, Iisawa Y, Wagner RD, Czuprynski CJ. Administration of anti-IL-4 monoclonal antibody 11B11 increases resistance of mice to Listeria monocytogenes infection. J. Immunol. 1992; 148: 3978-85.
19. 19 Dai WJ, Kohler G, Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 1997; 158: 2259-67.
20. 20 Leong KH, Ramsay A, Boyle DB, Ramshaw IA. Selective induction of immune responses by cytokines co-expressed in recombinant fowlpox virus. J Virol. 1994; 68: 8125.
21. 21 Reynolds DS, Boom WH, Abbas AK, Inhibition of B lymphocyte activation by interferon gamma. J. Immunol. 1987; 139: 767-73.
22. 22 Saunders BM, Cheers C. Intranasal infection of beige mice with Mycobacterium avium: Role of neutrophils and natural killer cells. Infect. Immun. 1996; 64: 4236-41.
23. 23 Cheers C, McKenzie IFC, Pavlov H, Waid C, York J. Resistance and susceptibility of mice to bacterial infection. II. Course of listeriosis in resistant or susceptible mice. Infect. Immun. 1978; 19: 763-70.
24. 24 Tran HTT, Cook AD, Ganas M, Cheers C. Distinction between 'inflammatory' and 'immune' macrophages killing Listeria monocytogenes in murine infection. Immunol. Cell Biol. 1990; 68: 285-93.
25. 25 Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 1993; 5: 503-10.
26. 26 Greenberger MJ, Kunkel SL, Strieter RM et al. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol. 1996; 157: 3006-12.
27. 27 Kiderlen A, Kaufmann S, Lohmann-Mathes M. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur. J. Immunol. 1984; 14: 964-7.
28. 28 Buchmeier NA, Schreiber RD. Requirement for endogenous interferon γ production for resolution of Listeria monocytogenes infection. Proc. Natl Acad. Sci. USA 1985; 82: 7404-8.
29. 29 Iizawa Y, Czuprynski C. Effects of administration of murine recombinant IL-4 on the resistance of mice to Listeria monocytogenes infection. Immunol. Lett. 1992; 32: 185-9.
30. 30 Mosmann TR. T lymphocyte subsets, cytokines and effector functions. Ann. N Y Acad. Sci. 1992; 664: 89-92.
31. 31 Miki K, Mackaness GB. The passive transfer of acquired resistance to Listeria monocytogenes. J. Exp. Med. 1964; 120: 93-103.
32. 32 Zhan Y, Liu Z, Cheers C. TNF-α and IL-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 1996; 64: 2782-6.
33. 33 Saunders B, Cheers C. Inflammatory response following intranasal infection with Mycobacterium avium complex Role of T cell subsets and interferon-gamma. Infect. Immun. 1995; 63: 2282-7.